Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta (R) in the prophylactic treatment of chemotherapy-induced neutropenia-MedSci.cn

Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta (R) in the prophylactic treatment of chemotherapy-induced neutropenia

Waller, C; Blakeley, C; Pennella, E; Bronchud, MH; Mattano, L; Berzoy, O; Voitko, N; Adamchuk, H; Zautashvili, Z; Vinnyk, Y; Nemsadze, G; Dzagnidze, G; Shparyk, Y; Lytvyn, I; Rusyn, A; Popov, V; Lang, I; Sharma, R; Baczkowski, M; Kothekar, M

EUROPEAN JOURNAL OF CANCER, 2017; 72 ( ): S42

科室
- - 订阅+
  - 更多科室
工具
服务